Your browser doesn't support JavaScript. Please upgrade to a modern browser or enable JavaScript in your existing browser.
Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
www.ahrq.gov


Appendix Table 5. Studies Excluded from Key Question 2

Study Citation Reason for Exclusion
Adams PC, Kertesz AE, Valberg LS. Rate of iron reaccumulation following iron depletion in hereditary hemochromatosis. Implications for venesection therapy. J Clin Gastroenterol 1993;16:207-10. [PMID: 8505491] Does not present relevant outcomes
Adams PC. Factors affecting the rate of iron mobilization during venesection therapy for genetic hemochromatosis. Am J Hematol 1998;58:16-9. [PMID: 9590143] Does not present relevant outcomes
Askari AD, Muir WA, Rosner IA, Moskowitz RW, McLaren GD, Braun WE. Arthritis of hemochromatosis. Clinical spectrum, relation to histocompatibility antigens, and effectiveness of early phlebotomy. Am J Med 1983;75:957-65. [PMID: 6650551] Quality
Barton JC, Bottomley SS. Iron deficiency due to excessive therapeutic phlebotomy in hemochromatosis. Am J Hematol 2000;65:223-6. [PMID: 11074539] < 20 patients
Batey RG, Hussein S, Sherlock S, Hoffbrand AV. The role of serum ferritin in the management of idiopathic haemochromatosis. Scand J Gastroenterol 1978;13:953-7. [PMID: 725519] Does not present relevant outcomes
Bodemann HH, Tanzi-Fetta RF, Schroter-Urban H, Volk BA, Keul J, Lohr GW. Ferritin in erythrocytes and plasma of patients with iron overload. Blut 1985;51:25-31. [PMID: 3848335] Quality
Candell-Riera J, Lu L, Seres L, Gonzalez JB, Batlle J, Permanyer-Miralda G, et al. Cardiac hemochromatosis: beneficial effects of iron removal therapy. An echocardiographic study. Am J Cardiol 1983;52:824-9. [PMID: 6624673] Quality
Cesana M, Mandelli C, Tiribelli C, Bianchi PA, Conte D. Concomitant primary hemochromatosis and beta-thalassemia trait: iron depletion by erythrocytapheresis and desferrioxamine. Am J Gastroenterol 1989;84:150-2. [PMID: 2916524] < 20 patients
Chow LH, Frei JV, Hodsman AB, Valberg LS. Low serum 25-hydroxyvitamin D in hereditary hemochromatosis: relation to iron status. Gastroenterology 1985;88:865-9. [PMID: 3838288] Quality
Cleton MI, de Bruijn WC, van Blokland WT, Marx JJ, Roelofs JM, Rademakers LH. Iron content and acid phosphatase activity in hepatic parenchymal lysosomes of patients with hemochromatosis before and after phlebotomy treatment. Ultrastruct Pathol 1988;12:161-74. [PMID: 3363682] < 20 patients
Cleton MI, Roelofs JM, Blok-Van Hoek CJ, De Bruijn WC. Integrated image and X-ray microanalysis of hepatic lysosomes in a patient with idiopathic hemosiderosis before and after treatment by phlebotomy. Scan Electron Microsc 1986:999-1006. [PMID: 3798023] < 20 patients
Conte D, Mandelli C, Cesana M, Ferrini R, Marconi M, Bianchi A. Effectiveness of erythrocytapheresis in idiopathic hemochromatosis. Report of 14 cases. Int J Artif Organs 1989;12:59-62. [PMID: 2925263] Does not report relevant outcomes
Conte D, Piperno A, Mandelli C, Fargion S, Cesana M, Brunelli L, et al. Clinical, biochemical and histological features of primary haemochromatosis: a report of 67 cases. Liver 1986;6:310-5. [PMID: 3023781] Quality
Cundy T, Butler J, Bomford A, Williams R. Reversibility of hypogonadotrophic hypogonadism associated with genetic haemochromatosis. Clin Endocrinol (Oxf). 1993;38:617-20. [PMID: 8334747] < 20 patients
Dabestani A, Child JS, Henze E, Perloff JK, Schon H, Figueroa WG, et al. Primary hemochromatosis: anatomic and physiologic characteristics of the cardiac ventricles and their response to phlebotomy. Am J Cardiol 1984;54:153-9. [PMID: 6741807] < 20 patients
Dymock IW, Cassar J, Pyke DA, Oakley WG, Williams R. Observations on the pathogenesis, complications and treatment of diabetes in 115 cases of haemochromatosis. Am J Med 1972;52:203-10. [PMID: 5058506] Quality
Easley RM Jr, Schreiner BF Jr, Yu PN. Reversible cardiomyopathy associated with hemochromatosis. N Engl J Med 1972;287:866-7. [PMID: 5071966] < 20 patients
Failla M, Giannattasio C, Piperno A, Vergani A, Grappiolo A, Gentile G, et al. Radial artery wall alterations in genetic hemochromatosis before and after iron depletion therapy. Hepatology 2000;32:569-73. [PMID: 10960451] < 20 patients
Fargion S, Mandelli C, Piperno A, Cesana B, Fracanzani AL, Fraquelli M, et al. Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis. Hepatology 1992;15:655-9. [PMID: 1312985] Quality
Feely J, Counihan TB. Haemochromatosis presenting as angina and responding to venesection. Br Med J 1977;2:681-2. [PMID: 902053] < 20 patients
Fellows IW, Stewart M, Jeffcoate WJ, Smith PG, Toghill PJ. Hepatocellular carcinoma in primary haemochromatosis in the absence of cirrhosis. Gut 1988;29:1603-6. [PMID: 2850272] < 20 patients
Fracanzani AL, Fargion S, Romano R, Conte D, Piperno A, D'Alba R, et al. Portal hypertension and iron depletion in patients with genetic hemochromatosis. Hepatology 1995;22:1127-31. [PMID: 7557861] Quality
Gama R, Smith MJ, Wright J, Marks V. Hypopituitarism in primary haemochromatosis; recovery after iron depletion. Postgrad Med J 1995;71:297-8. [PMID: 7596937] < 20 patients
Goh J, Callagy G, McEntee G, O'Keane JC, Bomford A, Crowe J. Hepatocellular carcinoma arising in the absence of cirrhosis in genetic haemochromatosis: three case reports and review of literature. Eur J Gastroenterol Hepatol 1999;11:915-9. [PMID: 10514128] < 20 patients
Grima KM. Therapeutic apheresis in hematological and oncological diseases. J Clin Apher 2000;15:28-52. [PMID: 10767050] Review article
Guillygomarc'h A, Mendler MH, Moirand R, Laine F, Quentin V, David V, et al. Venesection therapy of insulin resistance-associated hepatic iron overload. J Hepatol 2001;35:344-9. [PMID: 11592595] Wrong population
Hash RB. Hereditary hemochromatosis. J Am Board Fam Pract 2001;14:266-73. [PMID: 11458969] Review article Hines C Jr, Davis WD Jr, Ferrante WA. Hepatoma developing in hemochromatosis in spite of adequate treatment by multiple phlebotomies. Am J Dig Dis 1971;16:349-55. [PMID: 4324431] Case report
Hramiak IM, Finegood DT, Adams PC. Factors affecting glucose tolerance in hereditary hemochromatosis. Clin Invest Med 1997;20:110-8. [PMID: 9088667] Quality
Hultcrantz R, Angelin B, Bjorn-Rasmussen E, Ewerth S, Einarsson K. Biliary excretion of iron and ferritin in idiopathic hemochromatosis. Gastroenterology 1989;96:1539-45. [PMID: 2714579] Quality
Jakeman A, Thompson T, McHattie J, Lehotay DC. Sensitive method for nontransferrin-bound iron quantification by graphite furnace atomic absorption spectrometry. Clin Biochem 2001;34:43-7. [PMID: 11239514] < 20 patients
Kaltwasser JP, Werner E, Schalk K, Hansen C, Gottschalk R, Seidl C. Clinical trial on the effect of regular tea drinking on iron accumulation in genetic haemochromatosis. Gut 1998;43:699-704. [PMID: 9824354] Quality
Kelly TM, Edwards CQ, Meikle AW, Kushner JP. Hypogonadism in hemochromatosis: reversal with iron depletion. Ann Intern Med 1984;101:629-32. [PMID: 6435491] Does not present relevant outcomes
Kohan A, Niborski R, Daruich J, Rey J, Bastos F, Amerise G, et al. Erythrocytapheresis with recombinant human erythropoietin in hereditary hemochromatosis therapy: a new alternative. Vox Sang 2000;79:40-5. [PMID: 10971213] < 20 patients
Leitman SF, Browning JN, Yau YY, Mason G, Klein HG, Conry-Cantilena C, et al. Hemochromatosis subjects as allogeneic blood donors: a prospective study. Transfusion 2003;43:1538-44. [PMID: 14617312] Does not report relevant outcomes
Limdi JK, Crampton JR. Hereditary haemochromatosis. QJM 2004;97:315-24. [PMID: 15152104] Review article
Lombard M, Bomford A, Hynes M, Naoumov NV, Roberts S, Crowe J, et al. Regulation of the hepatic transferrin receptor in hereditary hemochromatosis. Hepatology 1989;9:1-5. [PMID: 2642288] Does not present relevant outcomes
Lufkin EG, Baldus WP, Bergstralh EJ, Kao PC. Influence of phlebotomy treatment on abnormal hypothalamic-pituitary function in genetic hemochromatosis. Mayo Clin Proc 1987;62:473-9. [PMID: 3106726] Quality
Mainous AG 3rd, Wells B, Carek PJ, Gill JM, Geesey ME. The mortality risk of elevated serum transferrin saturation and consumption of dietary iron. Ann Fam Med 2004;2:139-44. [PMID: 15083854] No phlebotomy treatment
Mandelli C, Cesarini L, Piperno A, Fargion S, Fracanzani AL, Barisani D, et al. Saturability of hepatic iron deposits in genetic hemochromatosis. Hepatology 1992;16:956-9. [PMID: 1398502] Does not present relevant outcomes
McDonnell SM, Witte DL, Cogswell ME, McIntyre R. Strategies to increase detection of hemochromatosis. Ann Intern Med 1998;129:987-92. [PMID: 9867752] Review article
Milman N, Pedersen P, a Steig T, Byg KE, Graudal N, Fenger K. Clinically overt hereditary hemochromatosis in Denmark 1948-1985: epidemiology, factors of significance for long-term survival, and causes of death in 179 patients. Ann Hematol 2001;80:737-44. [PMID: 11797115] Quality
Milman N. Hereditary haemochromatosis in Denmark 1950-1985. Clinical, biochemical and histological features in 179 patients and 13 preclinical cases. Dan Med Bull 1991;38:385-93. [PMID: 1914539] Does not report relevant outcomes
Moirand R, Adams PC, Bicheler V, Brissot P, Deugnier Y. Clinical features of genetic hemochromatosis in women compared with men. Ann Intern Med 1997;127:105-10. [PMID: 9229998] Does not report relevant outcomes
Morcos M, Dubois S, Bralet MP, Belghiti J, Degott C, Terris B. Primary liver carcinoma in genetic hemochromatosis reveals a broad histologic spectrum. Am J Clin Pathol 2001;116:738-43. [PMID: 11710692] Does not report relevant outcomes
Muncunill J, Vaquer P, Galmes A, Obrador A, Parera M, Bargay J, et al. In hereditary hemochromatosis, red cell apheresis removes excess iron twice as fast as manual whole blood phlebotomy. J Clin Apher 2002;17:88-92. [PMID: 12210712] < 20 patients
Muting D, Kalk JF, Fischer R, Wiewel D. Spontaneous regression of oesophageal varices after long-term conservative treatment. Retrospective study in 20 patients with alcoholic liver cirrhosis, posthepatitic cirrhosis and haemochromatosis with cirrhosis. J Hepatol 1990;10:158-62. [PMID: 2332585] Not phlebotomy treatment
Niederau C, Stremmel W, Strohmeyer GW. Clinical spectrum and management of haemochromatosis. Baillieres Clin Haematol 1994;7:881-901. [PMID: 7881158] Review article
Niederau C, Strohmeyer G, Stremmel W. Epidemiology, clinical spectrum and prognosis of hemochromatosis. Adv Exp Med Biol 1994;356:293-302. [PMID: 7887234] Review article
Olsson KS, Ritter B, Lundin PM. Liver affection in iron overload studied with serum ferritin and serum aminotransferases. Acta Med Scand 1985;217:79-84. [PMID: 3976436] Quality
Piperno A, Vergani A, Salvioni A, Trombini P, Vigano M, Riva A, et al. Effects of venesections and restricted diet in patients with the insulin-resistance hepatic iron overload syndrome. Liver Int 2004;24:471-6. [PMID: 15482345] Does not report relevant outcomes
Propper R, Nathan D. Clinical removal of iron. Annu Rev Med 1982;33:509-19. [PMID: 6282184] Clinical review article Prunescu CC, Prunescu P, Vilcu AL. Ultrastructure of the liver in idiopathic haemosiderosis and results of a treatment by repeated bleedings. Morphol Embryol (Bucur) 1987;33:133-6. [PMID: 2956507] Case report
Riquelme A, Soza A, Nazal L, Martinez G, Kolbach M, Patillo A, et al. Histological resolution of steatohepatitis after iron depletion. Dig Dis Sci 2004;49:1012-5. [PMID: 15309893] Case report
Sargent T, Saito H, Winchell HS. Iron absorption in hemochromatosis before and after phlebotomy therapy. J Nucl Med 1971;12:660-7. [PMID: 5000107] Does not report relevant outcomes
Seamark CJ, Hutchinson M. Controversy in primary care: Should asymptomatic haemochromatosis be treated? BMJ 2000;320:1314-7. [PMID: 10807626] Case report
Sigal SH, Fleischner GM, Weiner FR. Hypogonadal-induced anemia in genetic hemochromatosis: implications for phlebotomy therapy. Am J Gastroenterol 1995;90:152-3. [PMID: 7801923] Case report
Spellberg MA. Treatment of hemochromatosis. Am J Gastroenterol 1969;51:516-22. [PMID: 4894612] Review article
Tiniakos G, Williams R. Cirrhotic process, liver cell carcinoma and extrahepatic malignant tumors in idiopathic haemochromatosis. Study of 71 patients treated with venesection therapy. Appl Pathol 1988;6:128-38. [PMID: 2839215] Quality
Weintraub LR, Conrad ME, Crosby WH. The treatment of hemochromatosis by phlebotomy. Med Clin North Am 1966;50:1579-90. [PMID: 5339192] < 20 patients

Return to Document
Proceed to Next Table

 

AHRQ Advancing Excellence in Health Care